Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents J Roy, SU Hettiarachchi, M Kaake, R Mukkamala, PS Low Theranostics 10 (13), 5778, 2020 | 31 | 2020 |
Synthesis of Benzyl C‐Analogues of Dapagliflozin as Potential SGLT2 Inhibitors R Mukkamala, R Kumar, SK Banerjee, IS Aidhen European Journal of Organic Chemistry 2020 (12), 1828-1839, 2020 | 28 | 2020 |
Metal-free bipolar/octupolar organic dyes for DSSC application: A combined experimental and theoretical approach S Mandal, S Kushwaha, R Mukkamala, VK Siripina, IS Aidhen, ... Organic Electronics 36, 177-184, 2016 | 27 | 2016 |
Exploring the role of the spacers and acceptors on the triphenylamine-based dyes for dye-sensitized solar cells J Sivanadanam, R Mukkamala, S Mandal, R Vedarajan, N Matsumi, ... International Journal of Hydrogen Energy 43 (9), 4691-4705, 2018 | 26 | 2018 |
A common building block for the syntheses of amorfrutin and cajaninstilbene acid libraries toward efficient binding with peroxisome proliferator-activated receptors IS Aidhen, R Mukkamala, C Weidner, S Sauer Organic letters 17 (2), 194-197, 2015 | 26 | 2015 |
Iodine‐Promoted Oxidative Conversion of o‐Vinyl Diaryl Ketones into o‐Acetyl Diaryl Ketones, Synthesis of 1‐Methyl‐4‐arylphthalazines as Analogues of … K Harikrishna, R Mukkamala, B Hinkelmann, F Sasse, IS Aidhen European Journal of Organic Chemistry 2014 (5), 1066-1075, 2014 | 16 | 2014 |
Enhanced two photon absorption cross section and optical nonlinearity of a quasi-octupolar molecule CKR Namboodiri, SR Bongu, PB Bisht, R Mukkamala, B Chandra, ... Journal of Photochemistry and Photobiology, A: Chemistry 314, 60-65, 2016 | 13 | 2016 |
Solvatochromism, multiphoton fluorescence, and resonance energy transfer in a new octupolar dye-pair CKR Namboodiri, PB Bisht, R Mukkamala, B Chandra, IS Aidhen Chemical Physics 415 (https://doi.org/10.1016/j.chemphys.2013.), 190-195, 2013 | 11 | 2013 |
Design and characterization of fibroblast activation protein targeted pan-cancer imaging agent for fluorescence-guided surgery of solid tumors R Mukkamala, SD Lindeman, KA Kragness, I Shahriar, M Srinivasarao, ... Journal of Materials Chemistry B 10 (12), 2038-2046, 2022 | 10 | 2022 |
Convenient Access to Acyl‐Substituted Bis (styrylbenzenes) Based on Building Blocks Using Julia Olefination and Weinreb Amide Chemistry R Mukkamala, A Senthilmurugan, IS Aidhen European Journal of Organic Chemistry 2013 (11), 2216-2229, 2013 | 9 | 2013 |
Valuable building block for the synthesis of lunularic acid, hydrangeic acid and their analogues R Mukkamala, A Hossain, I Singh Aidhen Natural product research 31 (9), 1085-1090, 2017 | 6 | 2017 |
Fibroblast activation protein–targeted radioligand therapy for treatment of solid tumors SD Lindeman, R Mukkamala, A Horner, P Tudi, OC Booth, R Huff, ... Journal of Nuclear Medicine 64 (5), 759-766, 2023 | 5 | 2023 |
Fibroblast activation protein (fap)-targeted imaging and therapy of cancers and other fibrotic and inflammatory diseases PS Low, M Srinivasarao, R Mukkamala US Patent App. 17/761,508, 2022 | 3 | 2022 |
Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors BT Nicole Dmochowska, Valentina Milanova, Ramesh Mukkamala, Kwok Keung Chow ... Small, https://doi.org/10.1002/smll.202204956, 2023 | 2* | 2023 |
Novel fibroblast activation protein targeting radioligand for imaging and radiotherapy of solid tumors R Mukkamala, LD Spencer, CJ Daniel, P Tudi, MN Kaine, A Horner, ... Cancer Research 84 (6_Supplement), 1119-1119, 2024 | | 2024 |
Fibroblast activation protein-targeted magnetic resonance imaging agents, compositions, and methods of use PS Low, R Mukkamala, M Srinivasarao US Patent App. 18/336,708, 2023 | | 2023 |
Dual targeting of tumor cells and cancer associated fibroblasts enhances CAR T efficacy in solid tumors B Huang, S Zheng, H Chu, R Mukkamala, SK Bowroju, Y Singh, ... Cancer Research 83 (7_Supplement), 4099-4099, 2023 | | 2023 |
Design of bispecific adapters for universal CAR T cell therapies of solid tumors S Zheng, B Huang, Y Singh, H Chu, SK Bowroju, MS Bari, M Srinivasarao, ... Cancer Research 83 (7_Supplement), 1787-1787, 2023 | | 2023 |
Abstract A016: Selective delivery of fibroblast activation protein conjugated dual phosphoinositide 3-kinase–AKT Kinase-mTOR inhibitor associated with decreased tumor … F Azari, GT Kennedy, A Chang, B Nadeem, A Din, I Marfatia, S Albelda, ... Clinical Cancer Research 28 (18_Supplement), A016-A016, 2022 | | 2022 |
Multivalent fibroblast-targeted agents and methods of use PS Low, M Srinivasarao, R Mukkamala US Patent App. 17/629,252, 2022 | | 2022 |